Lv12
50 积分 2024-04-15 加入
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
2小时前
待确认
Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study
21小时前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
9天前
已关闭
PET/CT in Non-Hodgkin Lymphoma: An Update
12天前
已完结
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2个月前
已完结
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet
2个月前
已完结
Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer
3个月前
已完结
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
3个月前
已完结
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
3个月前
已完结
P1.13A.02 Tarlatamab Plus Durvalumab as First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial
3个月前
已关闭
皖公网安备34019202002308
